Number: 201304108 Principal Investigator: Chapman, William
Title: A Phase II Randomized Multicenter Placebo-Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant (OLT) Recipients with Hepatocellular Carcinoma (HCC)
Description: This is a research study for patients who received a liver transplant and are at high risk of liver cancer recurrence after liver transplant. It is not known whether sorafenib, the study medication, is effective in preventing cancer recurrence in high risk patients following liver transplantation. T...MORE
 Number: RTOG 1112 Principal Investigator: Olsen, Jeffrey
Title: Randomized Phase III Study of Sorafenib versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma
Description: The standard treatment for hepatocellular carcinoma that is unsuitable for surgery or regional therapy is sorafenib, an oral drug that has been shown to increase the survival of patients compared to no active treatment. Stereotactic body radiation therapy (SBRT), referring to the use of focused hig...MORE
 Number: 201306051 Principal Investigator: Tan, Benjamin
Title: A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs Placebo in Subjects with Hepatocellular Carcinoma Who Have Received Prior Sorafenib
Description: The purpose of this study is to find out if cabozantinib is effective in treating liver cancer. This study will also examine how safe cabozantinib is and how well people with liver cancer tolerate cabozantinib....MORE
 Number: 201202001 Principal Investigator: Zuckerman, Darryl
Title: A Phase III Clinical Trial Evaluating TheraSphere in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy
Description: The purpose of this research study is to examine whether adding treatment with TheraSphere early in the current standard for second-line chemotherapy treatment of metastatic colorectal cancer is better than the current treatment alone. Better means slowing or stopping the growth of liver tumors ...MORE
 Number: ACRIN 6690 Principal Investigator: Fowler, Kathryn
Title: A Prospective, Multicenter Comparison of Multiphase Contrast-Enhanced CT and Multiphase Contrast-Enhanced MRI for Diagnosis of Hepatocellular Carcinoma and Liver Transplant Allocation
 Number: 201106049 Principal Investigator: Chapman, William
Title: The Hepatic Research Registry
 Number: 201301098 Principal Investigator: Fowler, Kathryn
Title: A Revisit of Complete Radiologic Response of Colorectal Liver Metastases (Disappearing Lesions) in the Era of Eovist (Gadoxetate Disodium)
 Number: 201411069 Principal Investigator: Fields, Ryan
Title: Phase I Study of hepatic Arterial Infusion with Floxuridine and Dexamethasone in Combination with gemcitabine as Adjuvant Treatment after Resection of Intrahepatic Cholangiocarcinoma
Description: The purpose of this research study is to find out what effects, good and/or bad, the combination of drugs may have on you and your liver cancer at different dose levels. The study will also evaluate if this treatment works in delaying or stopping your cancer from coming back after surgery. Floxur...MORE